Workflow
Fava protein
icon
Search documents
Burcon Highlights Strong Year of Execution and Commercial Momentum in Shareholder Letter
TMX Newsfile· 2025-12-15 13:00
Core Insights - Burcon NutraScience Corporation is positioned for significant growth as it enters 2026, building on its commercial momentum and achievements in technology validation and manufacturing [2][10] Commercial Momentum and Sales Growth - Recent customer transitions from evaluation to commercial purchase orders highlight Burcon's product differentiation, including high purity and clean taste [3] - Revenue for calendar 2025 is projected to be between $1 million and $3 million, with a reaffirmed target of over $10 million for calendar 2026 due to increasing customer commitments [4] Proven Protein Technology Platform - A strategic partnership with RE ProMan LLC is enhancing the commercial deployment of Burcon's protein technology, ensuring scalable production to meet rising demand [5] - Successful validation of patented protein technologies at full commercial scale has reduced execution risk and confirmed Burcon's capability to deliver high-performance ingredients [6] Industry Demand Aligned with Burcon's Strengths - The demand for clean-label, better-tasting plant proteins is increasing among food and beverage manufacturers, aligning with Burcon's strengths and driving over 200 new customer projects [7] Financial Readiness - Burcon is finalizing a financing to support production investments and accelerate growth, with strong backing from insiders and manufacturing partners [8] - The financing aims to enhance the company's balance sheet and support near-term growth initiatives [9] Entering 2026 with Strong Momentum - Burcon is entering 2026 with a solid foundation, including proven technology, scalable facilities, and growing ingredient sales, with a clear path to achieving positive cash flow [10]